Helicobacter pylori
Material: | Pathogen detection: Gastric / duodenal biopsy in special transport medium Antibody detection: 1 lm serum PCR: Stool |
Methods: |
Amplifikationsverfahren → Real-time-PCR Ligandenassays → Enzyme Linked Immunosorbent Assay (ELISA) Kulturelle Untersuchungen → mikroaerophiler Atmosphäre | Reference range | IgG: < 20 U/ml IgA: < 20 U/ml PCR: negative |
Indication | Gastritis, ventricular ulcer, duodenal ulcer, gastric MALT-lymphoma, idiopathic thrombocytopenic purpura, possibly M. Menetrier, functional dyspepsia (debated) |
Please note | H. pylori prevalence in Germany is between 3 % (children) and 48 % (adults). It is markedly increased in immigrants (36 % - 86 %). 80 % of the infections are clinically symptomless. H. pylori may trigger chronic active gastritis. Potential consequences are duodenal or ventricular ulcers, adenocarcinoma of the stomach or MALT-syndrome. Taking proton pump inhibitors (PPI) and antibiotics, reduces pathogen density. This may lead to false negative results. Therefore, diagnostics should take place no earlier than 4 weeks after antibiotic treatment and at least 2 weeks after PPI treatment. Diagnostic via culture and PCR from biopsies taken endoscopically (invasive method) or via non-invasive methods such as urea breath test, PCR, IgG- and IgA antibodies in serum. An acute infection can be demonstrated by culture, PCR or urea breath test. A positive serological result only shows, that a previous confrontation with bacteria has taken place, it does not allow a statement about infection activity. Following sanitization, a significant fall in titer can be seen after 6 – 12 months. A false-negative serum test can be caused by missing immune answer. A resistance test is possible from a culture from gastric- / duodenal biopsies, testing for clarithromycin resistance by PCR is also possible from those kind of biopsies or stool. For initial diagnosis in children and for follow-up checks after eradication treatment in adults, the breath test (C13-urea breath test- only suitable for older children from the age of 8- please refer to function tests), or PCR are recommended. Checks of eradication treatment should be carried out no earlier than 4 weeks after therapy end. Please also refer to section “Helicobacter pylori C13 breath test” |
Accredited | ja |
More Results for the letter H
- HIV (Human immune deficiency virus) (HIV, HIVBL)
- HIV-antibodies, HIV-1-/HIV-2 screening test, HIV-1-/HIV-2 immunoblot
- HIV resistance assessment (HIVRES)
- HLA B27 (HLAB)
- PCR
- HLA DR, DQ (HLAD)
- HLA typing (HLA)
- Human leucocyte antigen, HLA-A, -B, -C, -DR, full typing
- HLA-B-27 (HLA27P)
- HLA-B-5701 (HLAB57)
- Holotranscobalamin (HOLO)
- HOMA-IR (evaluation of insulin resistance) (HOMA)
- Homocysteine, total (HOMOC)
- Homocystine (HOMOCU)
- Homogentisic acid (HOMOG)
- Homovanillic acid (HVS)
- Homovanillinic acid (HOMO04)
- HVA
- Hookworm (ANDUO, NECA)
- European hookworm, ancylostoma duodenale, necator americanus
- Howell-Jolly bodies (HOJO)
- HTLV-I/II (HTLV, HTLVQ)
- Human T-lymphotropic viruses, human T-cell leukemia viruses
- Human metapneumovirus (HMPV)
- Hydroxybutyrate (HYDR01)
- b-Hydroxybutyrate
- Hydroxycorticosteroids (-17) in urine (HYDRO17)
- Hydroxylase deficiency (CYP11B1), genetic analysis (11β-) (HYDR03(11b))
- Hydroxylase deficiency (CYP21), genetic analysis (21-) (HYDR02(21))
- Hydroxyprogesterone (17α-) (HYDR04(17α))
- Hydroxyproline, total in urine (HYPRU1)
- Hydroxypyren (1-) (HYDR06(1))
- metabolite of polycyclic aromatic hydrocarbons
- Hygiene examinations in hospital (HYG)
- Hymenolepis nana (HYMENO)
- Dwarf tapeworm